Related Experiment Video
Updated: Jun 21, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Antibiotic use and risk of autism spectrum disorder and attention-deficit/hyperactivity disorder: a population-based
Kai-Lin Yang1, Ting-An Yen2, Fang-Ju Lin1,3,4
1Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
Insights
Early childhood antibiotic exposure shows minimal impact on autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) risk. These findings suggest timely antibiotic use is appropriate, even with concerns about neurodevelopmental outcomes.
Area of Science:
- Neuroscience
- Pediatrics
- Pharmacology
Background:
- The gut-brain axis suggests a link between gut microbiota and neurodevelopment.
- Previous studies on early antibiotic exposure and autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD) risk have yielded inconsistent results.
Purpose of the Study:
- To investigate the hypothesis that antibacterial agent exposure in the first two years of life increases the risk of ASD and/or ADHD.
Main Methods:
- Retrospective cohort study utilizing Taiwan's National Health Insurance Research Database (2003-2019).
- Included singleton, full sibling, and exposure-discordant sibling pair cohorts.
- Analyzed children with at least one antibacterial prescription between 0-2 years and diagnosed with ASD/ADHD by age 15, adjusting for confounders using Cox proportional hazards models.
Main Results:
- Antibiotic exposure showed a marginal increase in ASD/ADHD risk in singleton (aHR: 1.06) and full sibling (aHR: 1.03) cohorts.
- A slight decrease in risk was observed in the exposure-discordant sibling pair cohort (aHR: 0.92).
- The study analyzed over 946,000 children in the singleton cohort alone.
Conclusions:
- Early life antibiotic exposure appears to have a minimal impact on the risk of ASD and/or ADHD.
- Given the marginal and near-null estimated effects, concerns should not prevent timely and appropriate antibiotic use.
- Further research may explore nuanced effects within specific antibiotic classes or exposure timings.
Background:
The gut microbiota is believed to influence neurodevelopment through the gut-brain axis, but prior studies have shown inconsistent results regarding early childhood antibiotic exposure and subsequent risk of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). The purpose of this study was to evaluate the hypothesis that exposure to antibacterial agents in the first 2 years of life increases the risk of ASD and/or ADHD.
Methods:
This was a retrospective cohort study using 2003-2019 data from the National Health Insurance Research Database in Taiwan. Livebirths born between 2004 and 2016 were identified and separated into singleton, full sibling, and exposure-discordant sibling pair cohorts. The exposure group included children who filled at least one prescription for antibacterial agents between 0 and 2 years old in outpatient settings. The outcome, ASD and/or ADHD, was defined by at least one inpatient or outpatient diagnosis. The maximum follow-up age was 15 years in this study. Potential neonatal, maternal and paternal confounders were adjusted for. Cox proportional hazards models were used to estimate the relative event risk.
Results:
The final sample contained 946,581 children in the singleton cohort, 1,142,693 children in the full sibling cohort, and 352,612 children in the exposure-discordant sibling pair cohort. Antibiotic exposure marginally increased the risk of ASD and/or ADHD in the singleton cohort (adjusted hazard ratio [aHR]: 1.06, 95% confidence interval [CI]: 1.04-1.07) and in the full sibling cohort (aHR: 1.03, 95% CI: 1.01-1.04). A slight decrease in the risk of ASD and/or ADHD was observed in the exposure-discordant sibling pair cohort (aHR: 0.92, 95% CI: 0.90-0.94).
Conclusions:
The results suggest that early life antibiotic exposure has minimal impact on the risk of ASD and/or ADHD. Given that the estimated effects are marginal and close to null, concerns about ASD and/or ADHD risk increase should not postpone or deter timely and reasonable antibiotic use.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Antibiotic Selection
Oppositional Defiant Disorder
Diagnostic Criteria and...

